Enanta Pharmaceuticals reported $319.02M in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Amgen AMGN:US $ 24380M 5281M
Anika Therapeutics ANIK:US $ 165.78M 11.98M
Arrowhead Research ARWR:US $ 384.6M 141.36M
AstraZeneca AZN:LN 26.69B 583M
Biogen BIIB:US $ 7162.3M 21.4M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Clovis Oncology CLVS:US $ 230.67M 65.69M
Enanta Pharmaceuticals ENTA:US $ 319.02M 2.13M
Gilead Sciences GILD:US $ 14200M 275M
GlaxoSmithKline GSK:LN 18.25B 688M
Halozyme Therapeutics HALO:US $ 1017.3M 17.55M
Heron Therapeutics HRTX:US $ 315.05M 51.77M
Insmed INSM:US $ 958.98M 79.21M
IONIS PHARMACEUT IONS:US $ 2156M 82.42M
Karyopharm Therapeutics KPTI:US $ 241.58M 31.92M
Ligand Pharmaceuticals LGND:US $ 432.08M 21.18M
Marinus Pharmaceuticals MRNS:US $ 153.49M 32.57M
Neurocrine Biosciences NBIX:US $ 1005.7M 104.4M
Novartis NOVN:VX 26.25B 2.45B
Novavax NVAX:US $ 2174.18M 180.81M
Ptc Therapeutics PTCT:US $ 1011.14M 55.09M
Sarepta Therapeutics SRPT:US $ 2185.31M 79.91M
Vertex Pharmaceuticals VRTX:US $ 8852.54M 395.03M
Vital Therapies VTL:US $ 122.5M 20.81M
YTE INCY:US $ 2923.8M 303.74M